Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs for Major Depressive Disorder

2 tracked Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs in the Major Depressive Disorder race. The class explanation lives on the Dopamine D2 and serotonin 5-HT2A receptors (antagonist) page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.

1 approved / phase 41 Phase 3

The roster

← all Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs